MarketInOut Stock Screener Log In | Sign Up
 

Sanofi ADR

NASDAQ • Healthcare • Drug Manufacturers - General • Quote as of 05/12/2026 16:00
Sanofi ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization103,764 mln
Float1,087 mln
Earnings Date07/23/2026

EPS

2.33
Solid

P / E

18.39
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.45
Borderline

1-Year Forecast

55.90
Strong upside

Relative Strength

27 / 100
Underperforming

Business Description

Sanofi is a Paris-based global pharmaceutical company founded in 1994 that researches, develops, and sells treatments across a wide range of medical areas, including rare diseases, cancer, neurology, and immune conditions, as well as a broad portfolio of vaccines. The company works with numerous partners to advance next-generation therapies, including AI-driven drug discovery, protein degradation treatments, genome editing, and antibody-based medicines. Through these collaborations, Sanofi aims to bring meaningful new treatment options to patients around the world.

Key Fundamentals

EPS2.33
P/E18.39
ROE11.06
RPS22.12
ROIC7.30
ROA6.29
Interest Cover15.34
EBITDA, mln14,513
EV / EBITDA8.73
EV / EBIT16.04
Revenue, mln54,328
EV / Revenue2.33

Financial Strength

Altman Z-Score1.64
Piotroski F-Score 7 / 9
Beneish M-Score-2.45
Price to Intrinsic Value0.74
Price to Graham Number3.52
1-Year Target Price55.90
Shiller PE Ratio12.89
Short Ratio2.50
Short % of Float0.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.15% 31 / 100   
1 Month -3.64% 21 / 100   
2 Months -4.73% 30 / 100   
6 Months -8.89% 30 / 100   
1 Year -9.33% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us